Novo Nordisk Drops Metsera Bid, Focuses on Pipeline
Update: 2025-11-10
Description
Novo Nordisk withdraws from Metsera bidding war, shares surge; Pfizer acquires Metsera for $65.60 per share, Novo Nordisk explores other opportunities in obesity and diabetes sectors.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
